Fulvestrant or Capecitabine Combined With Pyrotinib in HR-positive and HER2-Positive Metastatic Breast Cancer: A Multicenter, Randomized, Phase III Study
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Fulvestrant (Primary) ; Pyrotinib (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2020 New trial record